Literature DB >> 17768133

Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients.

Maria Teresa Petrucci, Cristiano Gallucci, Alessandro Agrillo, Maria Cristina Mustazza, Robin Foà.   

Abstract

Current treatments for bisphosphonate-associated osteonecrosis of the jaw (ONJ) in multiple myeloma patients have limited efficacy. The biological effects of ozone indicate it may be therapeutic for ONJ. We, here, report the efficacy of a 15-day course of antibiotics, surgery and ozone therapy in 12 MM patients with ONJ.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17768133     DOI： 10.3324/haematol.11096

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  19 in total

1.  The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells.

Authors:  Sıdıka Sinem Akdeniz; E Beyler; Y Korkmaz; E Yurtcu; U Ates; K Araz; F I Sahin; O Y Torun
Journal:  Clin Oral Investig       Date:  2017-07-11       Impact factor: 3.573

2.  Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients.

Authors:  Christian Walter; Bilal Al-Nawas; Norbert Frickhofen; Heinold Gamm; Joachim Beck; Laura Reinsch; Christina Blum; Knut A Grötz; Wilfried Wagner
Journal:  Head Face Med       Date:  2010-07-08       Impact factor: 2.151

Review 3.  Interventions for managing medication-related osteonecrosis of the jaw.

Authors:  Natalie H Beth-Tasdogan; Benjamin Mayer; Heba Hussein; Oliver Zolk; Jens-Uwe Peter
Journal:  Cochrane Database Syst Rev       Date:  2022-07-12

4.  Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up.

Authors:  Philipp Stockmann; Eleftherios Vairaktaris; Falk Wehrhan; Martin Seiss; Stephan Schwarz; Bernd Spriewald; Friedrich-Wilhelm Neukam; Emeka Nkenke
Journal:  Support Care Cancer       Date:  2009-07-17       Impact factor: 3.603

5.  Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol.

Authors:  Luca Ramaglia; Agostino Guida; Vincenzo Iorio-Siciliano; Alessandro Cuozzo; Andrea Blasi; Anton Sculean
Journal:  Clin Oral Investig       Date:  2018-01-13       Impact factor: 3.573

6.  Ozone treatment of alveolar bone in the cape chacma baboon does not enhance healing following trauma.

Authors:  Marthinus Kotze; Kürt-W Bütow; Steve A Olorunju; Harry F Kotze
Journal:  J Maxillofac Oral Surg       Date:  2013-03-16

7.  Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study.

Authors:  A Andriani; M T Petrucci; T Caravita; M Montanaro; N Villivà; A Levi; A Siniscalchi; V Bongarzoni; F Pisani; M De Muro; U Coppetelli; G Avvisati; A Zullo; A Agrillo; D Gaglioti
Journal:  Blood Cancer J       Date:  2012-03-23       Impact factor: 11.037

8.  The use of ozone in the prevention of osteoradionecrosis of the jaw.

Authors:  Goran Batinjan; Irina Filipovic Zore; Marko Vuletic; Ivana Rupic
Journal:  Saudi Med J       Date:  2014-10       Impact factor: 1.484

9.  Treatment of bisphosphonate related osteonecrosis following root canal therapy at the 1-year follow-up: report of two cases.

Authors:  Figen Kaptan; Meric Karapinar Kazandag; Ufuk Iseri
Journal:  Ther Clin Risk Manag       Date:  2013-12-02       Impact factor: 2.423

Review 10.  Interventions for managing medication-related osteonecrosis of the jaw.

Authors:  Natalie H Beth-Tasdogan; Benjamin Mayer; Heba Hussein; Oliver Zolk
Journal:  Cochrane Database Syst Rev       Date:  2017-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.